Jahan Marcu, Ph. D., is currently the Chief Scientific Officer and Chief Auditor for Americans for Safe Access and the Patient Focused Certification (PFC) Program. He is also on the Board of Directors of the International Association for Cannabinoids as Medicine (IACM). He received his Ph.D. for significant contributions to the study of the structure and function of the CB1 receptor, and the role of the endocannabinoid system in bone. Before earning his Ph.D., Dr. Marcu worked at the California Pacific Medical Center Research Institute studying the anti-cancer properties of compounds from the cannabis plant (Published in the Journal of Molecular Cancer Therapeutics) and on analytical Cannabis research projects in Holland.

His work has been covered by Forbes, Vice, Nature, the Philadelphia Inquirer, CannabisNow, the sensible science blog at freedomisgreen.com, Freedom Leaf Magazine, Washington Post and many other media outlets. He is also an author of the American Herbal Pharmacopoeia Cannabis Monograph.

Dr. Marcu serves on multiple expert government, trade association committees, and scientific organizations including AHPA, ACS, AOCS, AOAC, ASA, IACM, IMCPC and others. Dr. Marcu was the first recipient of the Billy Martin research award from the International Cannabinoid Research Society. He is a court-qualified synthetic cannabinoid and cannabis expert.